Patient tumor responses
| Total (N=58) | Primary PD-(L)1 Resistance (N=28) | Acquired PD-(L)1 Resistance (N=30) | |
| Complete response | 1 (2)* | 1 (4) | 0 |
| Partial response | 1 (2)* | 1 (4) | 0 |
| Stable disease/no response | 24 (41) | 10 (36) | 14 (47) |
| Increasing disease | 27 (47) | 12 (43) | 15 (50) |
| Symptomatic deterioration | 4 (7) | 3 (11) | 1 (3) |
| Assessment inadequate | 1 (2) | 1 (4) | 0 |
| Objective response rate | 2 (3 (95% CI 0 to 8)) | 2 (7 (95% CI 0 to 17)) | 0 |
| Disease control rate | 26 (45 (95% CI 32 to 58)) | 12 (43 (95% CI 25 to 61)) | 14 (47 (95% CI 29 to 65)) |
Values are shown as n (%) unless otherwise stated.
*Includes confirmed and unconfirmed responses per investigator assessment.
PD-L1, programmed death ligand 1.